CORY SEHRT: Open Payments
NPI 1215562517 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 29 payments from 15 companies in 2025. Trend: 2023 $1,655 · 2024 $1,402 · 2025 $592
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $140 |
| PFIZER INC. | 3 | $67 |
| Lilly USA, LLC | 2 | $42 |
| Verona Pharma, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| ABBVIE INC. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
Products named: FARXIGA, PREVNAR 20, MOUNJARO, Ohtuvayre, VOQUEZNA, NEXLETOL, Ozempic, UBRELVY.
Industry payments across CO — which companies pay providers there.
